Company Filing History:
Years Active: 2019
Title: Jordan Frandsen: Innovator in Cancer Gene Therapy
Introduction
Jordan Frandsen is a notable inventor based in Salt Lake City, UT. He has made significant contributions to the field of cancer gene therapy through his innovative work. His research focuses on developing advanced delivery systems for therapeutic applications.
Latest Patents
Frandsen holds a patent for "Matrix metalloproteinase cleavable protein polymers for cancer gene therapy." This delivery system includes a recombinantly synthesized protein polymer with protease cleavage sites, such as matrix metalloproteinase responsive sequences engineered within the protein polymer. The system is designed to treat cancer, wounds, or pathological conditions in tissues that express excess protease relative to healthy tissue. He has 1 patent to his name.
Career Highlights
Jordan Frandsen is affiliated with the University of Utah Research Foundation, where he continues to advance his research in cancer therapy. His work is pivotal in developing new methods for delivering therapeutic agents effectively.
Collaborations
Frandsen collaborates with esteemed colleagues, including Hamidreza Ghandehari and Joseph Cappello. Their combined expertise enhances the research and development of innovative solutions in the medical field.
Conclusion
Jordan Frandsen's contributions to cancer gene therapy exemplify the impact of innovative research in medicine. His work continues to pave the way for new therapeutic strategies that could significantly improve patient outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.